The clinical phenotype of Israeli patients with Q703K mutation in the NLRP3 gene
Merav Lidar(Sheba Medical Center), Yael Shinar(Sheba Medical Center), Gleb Slobodin(Bnai Zion Medical Center), Ronit Almog(Bnai Zion Medical Center), Yackov Berkun(Hadassah Medical Center), Hagit Peleg(Hadassah Medical Center), PJ Hashkes(Shaare Zedek Medical Center), Rinat Cohen(Sheba Medical Center), M Rozenbaum(Bnai Zion Medical Center), L Kali(Bnai Zion Medical Center), Avi Livneh(Sheba Medical Center), Aharon Kessel(Technion – Israel Institute of Technology), I Ben Zvi(Sheba Medical Center)
Cited by 2
Related Papers
The international EAACI/GA²LEN/EuroGuiDerm/APAAACI guideline for the definition, classification, diagnosis, and management of urticaria
|Allergy|2021|1.2k
EULAR recommendations for the management of familial Mediterranean fever
|Annals of the Rheumatic Diseases|2016|593
JAK1/2 inhibition with baricitinib in the treatment of autoinflammatory interferonopathies
|Journal of Clinical Investigation|2018|519